SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its Series C financing, ...

PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, further strengthened its leadership team with the addition of Bruno Poddevin, Ph.D., who brings ...

DNA Script, announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX ® platform across India. Under the agreement, ILS will distribute DNA ...

DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The ...

DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), ...

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co ...

A new initiative aims to develop a modular, automated platform for rapid, distributed production of high-fidelity DNA, supporting potential advances in personalized medicines, vaccines, and other ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially ...